VALSARTAN/HYDROCHLOROTHIAZIDE SANDOZ 80 mg/12.5 mg, film-coated tablet 90 tablets
Active ingredients: HYDROCHLOROTHIAZIDE, Valsartan
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALSARTAN/HYDROCHLOROTHIAZIDE SANDOZ 80 mg/12,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Nov 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65613289CIP74915280CIP133400949152803Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 12,500 mg · un comprimé | SA |
| VALSARTANcomprimé | 80,000 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.